Division of Translational Cancer Research
101 – 110 of 690
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance
- Contribution to journal › Article
-
Mark
Drug-resilient Cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional Regulation
- Contribution to journal › Article
-
Mark
Апалутамид в комбинации с андрогендепривационной терапией в клинических подгруппах пациентов с метастатическим кастрационно-чувствительным раком предстательной железы : подгрупповой анализ рандомизированного клинического исследования TITAN
- Contribution to journal › Article
-
Mark
Development of celiac-safe foods : prevention of transglutaminase 2 (TG2) deamidation of gluten in healthy non-celiac volunteers
- Contribution to journal › Article
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
- Contribution to journal › Article
-
Mark
Protumoral lipid droplet-loaded macrophages are enriched in human glioblastoma and can be therapeutically targeted
- Contribution to journal › Article
-
Mark
Characterization of somatic mutations in sporadic uveal melanoma and uveal melanoma in patients with germline BAP1 pathogenic variants
- Contribution to journal › Article
-
Mark
A Versatile and Upgraded Version of the LundTax Classification Algorithm Applied to Independent Cohorts
- Contribution to journal › Article
-
Mark
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study : ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy
- Contribution to journal › Article
-
Mark
The analytical and clinical validity of AI algorithms to score TILs in TNBC : can we use different machine learning models interchangeably?
- Contribution to journal › Article
